Select Sidearea

Populate the sidearea with useful widgets. It’s simple to add images, categories, latest post, social media icon links, tag clouds, and more.

hello@youremail.com
+1234567890

News Archive

SFA THERAPEUTICS INVITED TO PRESENT AT ANGEL VENTURE FAIR

Investors Meet Thirty of Top Startups in America-Angel Venture TUE, OCT 13 2020 9:00 AM—FRI, OCT 30 2020 4:00 PM SFA Therapeutics has been selected to present…

SFA THERAPEUTICS, INC. ANNOUNCES START OF PHASE 1b CLINICAL TRIAL IN THE TREATMENT OF MILD-TO-MODERATE PLAQUE PSORIASIS

JENKINTOWN, PA, UNITED STATES, April 8, 2021 /EINPresswire.com/ — SFA Therapeutics, Inc., a clinical-stage biotechnology company, is pleased to announced the start…

SFA Therapeutics Accepted To The Y-Combinator Accelerator Summer Cohort 2021

SFA Therapeutics was accepted into the highly competitive summer Y-Combinator Summer Cohort. Y-Combinator  is an American seed money startup accelerator launched…

2021 Most Fundable Company

Read More

Pismo Ventures’ National Venture Plan Startup Competition Announces Winners

EcoSoul Home and SFA Therapeutics (1st place tie,) Read More

SFA THERAPEUTICS, INC. CLOSES SEED ROUND RAISE of $4M

Funds are focused on Phase 1b clinical trial in psoriasis Read More

SFA Publishes new approach to treating Hepatitis B and Chronic Liver Disease, with the the goal of developing a functional cure

Abstract Patients who are carriers of the hepatitis B virus (HBV) are at high risk of chronic liver disease (CLD) which…

SFA Therapeutics to Present at Biotech Showcase, San Francisco, CA

BIOTECH SHOWCASE: THE INVESTOR CONFERENCE FOR INNOVATORS Ira Spector, CEO of SFA Therapeutics will be presenting a corporate update at the…

SFA Therapeutics CEO Quoted in the Wall Street Journal Article on Biotech Fundraising

Tales From the 2022 Biotech VC Fundraising Trail After the bonanza of 2021, life-sciences entrepreneurs reset their expectations as financing contracted…

SFA Therapeutics Announces FDA IND Approval To Begin NASH Trial

SFA Therapeutics will begin testing of SFA001 in a Phase 1 exploratory trial at Einstein Hospital in Philadelphia 1Q 2023 Dr…

SFA Therapeutics CEO Ira Spector Profiled in PharmaVoice

PROFILE A biotech CEO’s favorite ‘F’ word At SFA Therapeutics, patients are the “focus” of Ira Spector’s approach to changing the…